Mandy Meijer

Mandy Meijer

Auto-generated profile, based on publicly available information

Mandy Meijer

Edwin S.H. Leong Centre for Healthy Aging, University of British Columbia, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Science Advances
Verified
Journal Article
Open access
IZIoannis Zalachoras
Ioannis Zalachoras
SASimone Astori
Simone Astori
MMMandy Meijer
Mandy Meijer
JGJocelyn Grosse
Jocelyn Grosse
OZOlivia Zanoletti
Olivia Zanoletti
CSCarmen Sandi
Carmen Sandi
Individuals frequently differ in their behavioral and cognitive responses to stress. However, whether motivation is differently affected by acute stress in different individuals remains to be established. By exploiting natural variation in trait anxiety in outbred Wistar rats, we show that acute stress facilitates effort-related motivation in low anxious animals, while dampening effort in high anxious ones. This model allowed us to address the mechanisms underlying acute stress–induced differences in motivated behavior. We show that CRHR1 expression levels in dopamine neurons of the ventral tegmental area (VTA)—a neuronal type implicated in the regulation of motivation—depend on animals’ anxiety, and these differences in CRHR1 expression levels explain the divergent effects of stress on both effortful behavior and the functioning of mesolimbic DA neurons. These findings highlight CRHR1 in VTA DA neurons—whose levels vary with individuals’ anxiety—as a switching mechanism determining whether acute stress facilitates or dampens motivation.

1 January 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
JBJoão Paulo Brás
João Paulo Brás
ISIsabelle Guillot de Suduiraut
Isabelle Guillot de Suduiraut
OZOlivia Zanoletti
Olivia Zanoletti
SMSilvia Monari
Silvia Monari
MMMandy Meijer
Mandy Meijer
Maria Ines AlmeidaMaria Ines Almeida
Maria Ines Almeida

8 January 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JDJenny Van Dongen
Jenny Van Dongen
Fiona Alysa HagenbeekFiona Alysa Hagenbeek
Fiona Alysa Hagenbeek
MSMatthew Suderman
Matthew Suderman
PRPeter J. Roetman
Peter J. Roetman
KSKaren Sugden
Karen Sugden
Meike BartelsMeike Bartels
Meike Bartels
DNA methylation profiles of aggressive behavior may capture lifetime cumulative effects of genetic, stochastic, and environmental influences associated with aggression. Here, we report the first large meta-analysis of epigenome-wide association studies (EWAS) of aggressive behavior (N = 15,324 participants). In peripheral blood samples of 14,434 participants from 18 cohorts with mean ages ranging from 7 to 68 years, 13 methylation sites were significantly associated with aggression (alpha = 1.2 × 10−7; Bonferroni correction). In cord blood samples of 2425 children from five cohorts with aggression assessed at mean ages ranging from 4 to 7 years, 83% of these sites showed the same direction of association with childhood aggression (r = 0.74, p = 0.006) but no epigenome-wide significant sites were found. Top-sites (48 at a false discovery rate of 5% in the peripheral blood meta-analysis or in a combined meta-analysis of peripheral blood and cord blood) have been associated with chemical exposures, smoking, cognition, metabolic traits, and genetic variation (mQTLs). Three genes whose expression levels were associated with top-sites were previously linked to schizophrenia and general risk tolerance. At six CpGs, DNA methylation variation in blood mirrors variation in the brain. On average 44% (range = 3–82%) of the aggression–methylation association was explained by current and former smoking and BMI. These findings point at loci that are sensitive to chemical exposures with potential implications for neuronal functions. We hope these results to be a starting point for studies leading to applications as peripheral biomarkers and to reveal causal relationships with aggression and related traits.

24 October 2018 in Journal of Psychopharmacology
Verified
Journal Article
Open access
PDF file
Maria PanagiotouMaria Panagiotou
Maria Panagiotou
MMMandy Meijer
Mandy Meijer
JMJohanna H Meijer
Johanna H Meijer
Tom DeBoerTom DeBoer
Tom DeBoer
Background: Caffeine is one of the most widely consumed psychostimulants, and it impacts sleep and circadian physiology. Aim: Caffeine is generally used chronically on a daily basis. Therefore, in the current study, we investigated the chronic effect of caffeine on sleep in mice. Methods: We recorded the electroencephalogram and electromyogram on a control day, on the first day of caffeine consumption (acute), and following two weeks of continuous caffeine consumption (chronic). In the latter condition, a period of six-hour sleep deprivation was conducted during the light period. Control mice, which received normal drinking water, were also recorded and sleep deprived. Results: We found that caffeine induced differential effects following acute and chronic consumption. Over 24 h, waking increased following acute caffeine whereas no changes were found in the chronic condition. The daily amplitude of sleep–wake states increased in both acute and chronic conditions, with the highest amplitude in the chronic condition, showing an increase in sleep during the light and an increase in waking during the dark. Furthermore, electroencephalogram slow-wave-activity in non-rapid eye-movement sleep was increased, compared with both control conditions, during the first half of the light period in the chronic condition. It was particularly challenging to keep the animals awake during the sleep deprivation period under chronic caffeine. Conclusions: Together the data suggest an increased sleep pressure under chronic caffeine. In contrast to the traditional conception on the impact on sleep, chronic caffeine intake seems to increase the daily sleep–wake cycle amplitude and increase sleep pressure in mice.

22 December 2022 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
MMMandy Meijer
Mandy Meijer
BFBarbara Franke
Barbara Franke
CSCarmen Sandi
Carmen Sandi
JSJonathan Sebat
Jonathan Sebat
DNA methylation (DNAm) is one of the most frequently studied epigenetic mechanisms facilitating the interplay of genomic and environmental factors, which can contribute to externalizing behaviours and related psychiatric disorders. Previous epigenome-wide association studies (EWAS) for externalizing behaviours have been limited in sample size, and, therefore, candidate genes and biomarkers with robust evidence are still lacking. We 1) performed a systematic literature review of EWAS of attention-deficit/hyperactivity disorder (ADHD)- and aggression-related behaviours conducted in peripheral tissue and cord blood and 2) combined the most strongly associated DNAm sites observed in individual studies (p < 10-3) to identify candidate genes and biological systems for ADHD and aggressive behaviours. We observed enrichment for neuronal processes and neuronal cell marker genes for ADHD. Astrocyte and granulocytes cell markers among genes annotated to DNAm sites were relevant for both ADHD and aggression-related behaviours. Only 1 % of the most significant epigenetic findings for ADHD/ADHD symptoms were likely to be directly explained by genetic factors involved in ADHD. Finally, we discuss how the field would greatly benefit from larger sample sizes and harmonization of assessment instruments.

1 May 2021 in Neurobiology of Stress
Verified
Journal Article
Open access
MMMandy Meijer
Mandy Meijer
AKArlin Keo
Arlin Keo
JLJudith M.C. van Leeuwen
Judith M.C. van Leeuwen
ODOleh Dzyubachyk
Oleh Dzyubachyk
OMOnno C. Meijer
Onno C. Meijer
AMAhmed Mahfouz
Ahmed Mahfouz
The biological mechanisms underlying inter-individual differences in human stress reactivity remain poorly understood. We aimed to identify the molecular underpinning of aberrant neural stress sensitivity in individuals at risk for schizophrenia. Linking mRNA expression data from the Allen Human Brain Atlas to task-based fMRI revealed 201 differentially expressed genes in cortex-specific brain regions differentially activated by stress in individuals with low (healthy siblings of schizophrenia patients) or high (healthy controls) stress sensitivity. These genes are associated with stress-related psychiatric disorders (e.g. schizophrenia and anxiety) and include markers for specific neuronal populations (e.g. ADCYAP1, GABRB1, SSTR1, and TNFRSF12A), neurotransmitter receptors (e.g. GRIN3A, SSTR1, GABRB1, and HTR1E), and signaling factors that interact with the corticosteroid receptor and hypothalamic-pituitary-adrenal axis (e.g. ADCYAP1, IGSF11, and PKIA). Overall, the identified genes potentially underlie altered stress reactivity in individuals at risk for schizophrenia and other psychiatric disorders and play a role in mounting an adaptive stress response in at-risk individuals, making them potentially druggable targets for stress-related diseases.